[go: up one dir, main page]

DK1459739T3 - Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer - Google Patents

Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer

Info

Publication number
DK1459739T3
DK1459739T3 DK03006160T DK03006160T DK1459739T3 DK 1459739 T3 DK1459739 T3 DK 1459739T3 DK 03006160 T DK03006160 T DK 03006160T DK 03006160 T DK03006160 T DK 03006160T DK 1459739 T3 DK1459739 T3 DK 1459739T3
Authority
DK
Denmark
Prior art keywords
hydroscopic
quinoline carboxylic
pharmaceutical compositions
carboxylic acids
compositions containing
Prior art date
Application number
DK03006160T
Other languages
English (en)
Inventor
Adnan Dr Badwan
Lina Najati Nabulsi
Mahmoud M Omari
Original Assignee
Jordanian Pharmaceutical Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Mfg filed Critical Jordanian Pharmaceutical Mfg
Application granted granted Critical
Publication of DK1459739T3 publication Critical patent/DK1459739T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03006160T 2003-03-19 2003-03-19 Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer DK1459739T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03006160A EP1459739B1 (en) 2003-03-19 2003-03-19 Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids

Publications (1)

Publication Number Publication Date
DK1459739T3 true DK1459739T3 (da) 2008-05-19

Family

ID=32798836

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03006160T DK1459739T3 (da) 2003-03-19 2003-03-19 Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer

Country Status (7)

Country Link
US (1) US20040224014A1 (da)
EP (1) EP1459739B1 (da)
JP (1) JP2004339198A (da)
AT (1) ATE382338T1 (da)
DE (1) DE60318384T2 (da)
DK (1) DK1459739T3 (da)
ES (1) ES2297067T3 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006110815A1 (en) * 2005-04-11 2006-10-19 Abbott Laboratories Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CN104173323B (zh) * 2005-05-18 2018-04-03 拉普特制药有限公司 气溶胶化的氟喹诺酮类药物及其应用
EP2101733B1 (en) 2006-12-13 2012-09-26 F. Hoffmann-La Roche AG Powder formulation for valganciclovir
SI2346509T1 (sl) 2008-10-07 2020-08-31 Horizon Orphan Llc Inhalacija levofloksacina za zmanjšanje vnetja pljuč
MX345158B (es) 2008-10-07 2017-01-18 Raptor Pharmaceuticals Inc Formulaciones de fluoroquinolona en aerosol para farmacocinetica mejorada.
CA2773033C (en) 2009-09-04 2016-10-11 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis
BR112014012994A2 (pt) * 2011-11-30 2017-06-13 Toyama Chemical Co Ltd tablete contendo hidrato de metanossulfonato do ácido 1-ciclopropil-8-(difluorometóxi)-7-[(1r)-1-metil-2,3-diidro-1h-isoindol-5-il]-4-oxo-1, 4-diidroquinolina-3-carboxílico
JP5700740B1 (ja) 2013-04-25 2015-04-15 杏林製薬株式会社 固形医薬組成物
WO2014174846A1 (ja) 2013-04-25 2014-10-30 杏林製薬株式会社 固形医薬組成物
CA2965473A1 (en) 2014-10-23 2016-04-28 Kyorin-Pharmaceutical Co., Ltd. Solid pharmaceutical composition
CN106310229A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种马昔瑞林薄膜衣片及其制备方法
CN107115312A (zh) * 2017-05-17 2017-09-01 湖南新汇制药股份有限公司 一种诺氟沙星片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
CA2227314A1 (en) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
IT1319664B1 (it) * 2000-11-17 2003-10-23 Pharma Biotech Ltd Addotti di antibatterici chinolonici con polimeri polisaccaridicinaturali.

Also Published As

Publication number Publication date
JP2004339198A (ja) 2004-12-02
US20040224014A1 (en) 2004-11-11
ES2297067T3 (es) 2008-05-01
DE60318384D1 (de) 2008-02-14
ATE382338T1 (de) 2008-01-15
DE60318384T2 (de) 2009-02-19
EP1459739B1 (en) 2008-01-02
EP1459739A1 (en) 2004-09-22

Similar Documents

Publication Publication Date Title
DK1459739T3 (da) Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer
UA100966C2 (ru) Фармацевтическая композиция на основе 2-[4-(4-хлорбензоил)фенокси]-2-метилпропионовой кислоты и ее солей
DE60131088D1 (de) Gelierende wässrige pharmazeutische zusammensetzungen
MA30554B1 (fr) Malates et formes polymorphes de l'acide ( 3s,5s)-7-[3-amino-5-methyl-piperidinyl ]-1-cyclopropyl-1,4-dihydro-8- methoxy-4-oxo-3-quinoleine-carboxylique
CY2015045I1 (el) Φαρμακευτικες συνθεσεις ελεγχομενης απελευθερωσης που περιλαμβανουν εστερα φουμαρικου οξεος
DE60239425D1 (de) Kalziumatorvastatin enthaltende arzneiformulierung
ATE362314T1 (de) Herbizidzusammensetzungen umfassend imidazolinonsäure
EP2015762A4 (en) ANTIMICROBIAL COMPOSITIONS CONTAINING HEPAIC ACID ALKALISALES AND ITS USES
EP2036565A4 (en) PREPARATION FOR EXTERNAL APPLICATION TO THE SKIN WITH TRITERPENIC ACID
DK1396270T3 (da) Borsyresalte
IL174336A0 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
ES2189682B1 (es) Preparacion bebible que comprende ketoprofeno y su empleo en el tratamiento de procesos que cursan con fiebre, inflamacion y/o dolor, en un colectivo de animales, de forma simultanea.
DE602004019049D1 (de) Stabile feste medizinische zusammensetzung für die orale verabreichung von ramosetron
ATE162081T1 (de) Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
DE60025503D1 (de) Pharmazeutische Zusammensetzungen, die Faropenem Natrium und eine Diamineacetat Verbindung zur Verbesserung der Magen-Darm Trakt Absorption enthalten
NL194390B (nl) Farmaceutische samenstelling die analgetische activiteit bezit met (s)- 2-(6-methoxy-2-naftyl)propionzuur en arginine.
BR0311642A (pt) Formulação de divalproex de sódio de liberação aumentada
NO20021898L (no) Farmasoytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa
WO2008020314A3 (en) Statin stabilizing dosage formulations
ATE378335T1 (de) Chirale fluorochinolizinon arginine salze
PE20130180A1 (es) Soluciones farmaceuticas orales que comprenden telbivudina
MA30600B1 (fr) Formulation medicamenteuse aqueuse d'acide 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoique.
JO2567B1 (en) Non-water-absorbing pharmaceutical formula containing non-hydrated carboxylic quinoline acids
RU2006109966A (ru) Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных
BR0318460A (pt) sal de arginina de ácido benzoquinolizina-2-carboxìlico tetrahidratado